ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi

ClinicalTrials.gov ID: NCT04042025

Public ClinicalTrials.gov record NCT04042025. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 9:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-term Follow-up Study of Patients in the Clinical Trials for Spinal Muscular Atrophy Receiving AVXS-101

Study identification

NCT ID
NCT04042025
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Gene Therapies
Industry
Enrollment
85 participants

Conditions and interventions

Interventions

  • Onasemnogene Abeparvovec-xioi Biological

Biological

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 9, 2020
Primary completion
Dec 30, 2035
Completion
Dec 30, 2035
Last update posted
Apr 24, 2025

2020 – 2035

United States locations

U.S. sites
18
U.S. states
15
U.S. cities
17
Facility City State ZIP Site status
Stanford University Medical Center Palo Alto California 94304
Children's Hospital Colorado Aurora Colorado 80045
Ann Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611
John Hopkins Hospital - David M. Rubenstein Child Health Building Baltimore Maryland 21287
Massachusetts General Hospital Boston Massachusetts 02114
Boston Children's Hospital Boston Massachusetts 02115
Spectrum Health Hospitals Helen DeVos Children's Hospital Grand Rapids Michigan 49503
Washington Unviersity School of Medicine in Saint Louis St Louis Missouri 63110
Columbia University Medical Center New York New York 10032
Duke University Durham North Carolina 27713
Nationwide Children's Hospital Columbus Ohio 43205
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Clinic for Special Children Strasburg Pennsylvania 17579
Children's Health Specialty Center Dallas Campus Dallas Texas 75235
University of Utah Health Salt Lake City Utah 84112
Children's Hospital of The King's Daughters Norfolk Virginia 23507
Virginia Commonwealth University Richmond Virginia 23298
University of Wisconsin, Madison Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04042025, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2025 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04042025 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →